This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Topic Collections  • HIV/AIDS  • Nutritional and Metabolic Disorders, Other  • Diabetes Mellitus  • Alert me on articles by topic

Richard Trubo

JAMA. 2005;294:668-670.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

San Diego—With the widespread use of antiretroviral therapy, the life expectancy of many patients with HIV has increased substantially in recent years. As opportunistic infections have become less commonly associated with patient mortality, concerns are increasingly shifting to the impact of such chronic health conditions as diabetes mellitus and cardiovascular and liver diseases in this patient population.

In fact, the prevalence of diabetes and insulin resistance has grown among patients with HIV, and these conditions are "becoming increasingly recognized as a health problem for our patients," said Colleen M. Hadigan, MD, MPH, assistant professor of pediatrics at Harvard Medical School, Boston, Mass. At a symposium on secondary diabetes at the 65th Scientific Sessions of the American Diabetes Association here in June, she described the direct and indirect effects of antiretrovirals as significant contributors to insulin resistance in the presence of HIV infection.

HIV was only one of . . . [Full Text of this Article]

DETERMINING THE NUMBERS